Filing metadata

Accession number
0001193125-26-006407
Form type
Form 3
Filer
SAB Biotherapeutics, Inc.
CIK
CIK 1833214
Filed
Jan 07, 2026
Reporting period
Jan 05, 2026
Description
Initial ownership

Explore SEC Filings Hub